Schrodinger, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
SDGR on Nasdaq
Industry
Pharmaceutical Preparations
Location
1540 Broadway, 24 Th Floor, New York, NY

Insiders trading volume in the past year

Schrodinger, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shaw David E 10%+ Owner $549M Jun 14, 2021
Richard Friesner Director $30.1M Jun 18, 2025
Ramy Farid President & CEO, Director $6.21M Mar 3, 2025
Kenneth Patrick Lorton EVP, CTO & COO, Software $1.5M -$24.1K -1.58% Mar 3, 2025
Rachit Jain Evp & Cfo $955K May 21, 2025
Yvonne Tran Evp, Clo & Cpo $662K -$129K -16.4% Mar 3, 2025
Geoffrey Craig Porges Evp & Cfo $599K -$119K -16.6% Mar 3, 2025
Jenny Herman SVP & Controller $577K -$35K -5.72% Mar 6, 2025
Robert Lorne Abel EVP, Chief Scientific Officer, Platform $577K -$31.8K -5.23% Mar 3, 2025
Margaret Dugan Chief Medical Officer $518K -$29.4K -5.37% Oct 16, 2025
Nancy Thornberry Director $417K Jun 18, 2025
Gary Ginsberg Director $417K Jun 18, 2025
Gary Sender Director $417K Jun 18, 2025
Michael Lynton Director $417K Jun 18, 2025
Rosana Kapeller-Libermann Director $417K Jun 18, 2025
Jeffrey Chodakewitz Director $417K Jun 18, 2025
Arun Oberoi Director $417K Jun 18, 2025
Karen Akinsanya President of R&D, Therapeutics $391K -$420K -51.8% Apr 14, 2025
Mannix Vartan Aklian EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing $362K May 29, 2025
Bridget van Kralingen Director $278K Jun 18, 2025
Joel Lebowitz Evp & Cfo Sep 1, 2021

Recent Insider Transactions by Companies or Individuals for Schrodinger, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.